The group’s principal activity is to provide development of technologies to enable incisionless surgery the treatment of diseases through the natural passageways of the body. The group provides surgeons the operating platform and specialized tools. The group offers surgeons and gastroenterologists the tools they need to offer millions of potential patients a less invasive surgical option. The group operates from the United States.
